Tag: Prescription Drugs
Therapeutic Value of Drugs Lower for Supplemental Versus First Indications
For first three approved indications, second and third indication approvals less likely to have high value rating
Mirikizumab Tops Placebo for Moderately-to-Severely Active Ulcerative Colitis
Mirikizumab more effective for inducing and maintaining clinical remission in patients with ulcerative colitis
Long-Acting ART Achieves Virologic Suppression for People With HIV
97.5 percent were projected to achieve virologic suppression by a median of 33 weeks
Medical Cannabis Laws Seem Not to Have Affected Opioid, Nonopioid Therapy
No impact on receipt of opioid or nonopioid pain treatment seen among patients with chronic noncancer pain
Anesthesiologists Say Ozempic, Wegovy Should Be Halted Prior to Surgery
The drugs slow digestion and can increase risk for a patient vomiting while under anesthesia
Bulevirtide Linked to Decline in Hepatitis D Virus RNA Levels
Normalization of alanine aminotransferase also seen with bulevirtide 2- or 10-mg
Pegozafermin Leads to Improvements in Fibrosis in NASH
Improvements also seen in NASH resolution with pegozafermin 15 or 30 mg weekly, or 44 mg every two weeks
Meds Rarely Initiated After Discharge for Alcohol Use Disorder
Strongest demographic predictor for discharge initiation of medications for alcohol use disorder was younger age
CDC: Too Many Americans Cannot Access the Cure for Hepatitis C
Some state Medicaid programs and commercial insurers have restrictions that stand in the way of treatment
ADA: Reductions in Body Weight With Retatrutide for Obesity
Substantial reductions seen in body weight with retatrutide treatment for 48 weeks in phase 2 trial
